Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ross

JAMA

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|January 23, 1978
The family practice concept debatedM Ross
JAMA|November 10, 2005
Coffee consumption and development of type 2 diabetesCelia M Ross
JAMA|August 2, 1976
Mutilating lawn mower injuries in childrenP M Ross, E P Schwentker, H Bryan
JAMA|September 27, 1995
Helmets and preventing motorcycle and bicycle injuries: comments and a correctionM P Resnick, M Ross, T A Schmidt, et al.
JAMA|July 25, 1980
Psoriatic arthritis and aortic regurgitationW F Muna, D H Roller, J Craft, et al.
JAMA|April 27, 2016
Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" DesignationAaron S Kesselheim, Steven Woloshin, Wesley Eddings, et al.
JAMA|April 9, 1997
Patient-specific decisions about hormone replacement therapy in postmenopausal womenN F Col, M H Eckman, R H Karas, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|January 23, 1978
The family practice concept debatedM Ross
JAMA|November 10, 2005
Coffee consumption and development of type 2 diabetesCelia M Ross
JAMA|August 2, 1976
Mutilating lawn mower injuries in childrenP M Ross, E P Schwentker, H Bryan
JAMA|September 27, 1995
Helmets and preventing motorcycle and bicycle injuries: comments and a correctionM P Resnick, M Ross, T A Schmidt, et al.
JAMA|July 25, 1980
Psoriatic arthritis and aortic regurgitationW F Muna, D H Roller, J Craft, et al.
JAMA|April 27, 2016
Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" DesignationAaron S Kesselheim, Steven Woloshin, Wesley Eddings, et al.
JAMA|April 9, 1997
Patient-specific decisions about hormone replacement therapy in postmenopausal womenN F Col, M H Eckman, R H Karas, et al.
Pageof 1